Lipidomics reveals serum lipid metabolism disorders in CTD-induced liver injury

Cantharidin (CTD), the main toxic component of Mylabris, has been extensively used for tumor treatment in recent years. CTD-induced liver toxicity has attracted significant interest in clinic.

Source: BMC Clinical Pharmacology - January 15, 2024 Category: Drugs & Pharmacology Authors: Shan Li, Xiaotong Duan, Yixin Zhang, Cancan Zhao, Ming Yu, Xiaofei Li, Xiaomei Li and Jianyong Zhang Tags: Research Source Type: research